A detailed history of Marshall Wace, LLP transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 508,674 shares of RMTI stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
508,674
Holding current value
$1.07 Million
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.67 - $4.4 $849,485 - $2.24 Million
508,674 New
508,674 $2.02 Million
Q1 2024

May 15, 2024

SELL
$1.23 - $1.86 $95,039 - $143,718
-77,268 Reduced 44.13%
97,828 $162,000
Q4 2023

Feb 14, 2024

SELL
$1.58 - $2.44 $105,551 - $163,004
-66,805 Reduced 27.62%
175,096 $330,000
Q3 2023

Nov 14, 2023

BUY
$1.83 - $6.19 $413,203 - $1.4 Million
225,794 Added 1401.84%
241,901 $503,000
Q2 2023

Aug 14, 2023

BUY
$1.8 - $5.46 $28,992 - $87,944
16,107 New
16,107 $87,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $22.5M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.